Evidence map›Paper›PMID 35692732›Full record

ArticleMethodsX2022

Minimally invasive

Elizabeth A Bullard, Ariel I Mundo, Shelby N Bess, Kathryn Miller Priest, Timothy J Muldoon

Open access · goldAbstract read
In one paragraph

Article in MethodsX, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Elizabeth A BullardDepartment of Biomedical Engineering, University of Arkansas, Fayetteville, AR, United States.
Ariel I MundoDepartment of Biomedical Engineering, University of Arkansas, Fayetteville, AR, United States.
Shelby N BessDepartment of Biomedical Engineering, University of Arkansas, Fayetteville, AR, United States.
Kathryn Miller PriestDepartment of Biomedical Engineering, University of Arkansas, Fayetteville, AR, United States.
Timothy J MuldoonDepartment of Biomedical Engineering, University of Arkansas, Fayetteville, AR, United States.
University of Arkansas at Fayetteville · US

Funding

Unraveling Gene-Environment Interactions Shaping Metabolism: A Multi-Omics Analysis in DrosophilaP20GM139768 · NIGMS · UNIVERSITY OF ARKANSAS AT FAYETTEVILLE · PI Joanna Fiddler · 2021 to 2026
$17.0M
The role of optical biomarkers in endoscopic detection and therapeutic monitoring of gastrointestinal cancerR15CA202662 · NCI · UNIVERSITY OF ARKANSAS AT FAYETTEVILLE · PI MULDOON, TIMOTHY J · 2016 to 2016
$442k
NCI NIH HHS R15 CA202662NIGMS NIH HHS P20 GM139768
6 · The paper itself

Abstract

Ulcerative colitis (UC) is a gastrointestinal, autoimmune disease that causes ulceration and inflammation of the colon with an incidence of 10 out of every 100,000 people in North America and Western Europe. Though the specific cause is unknown, several studies have demonstrated that inflammatory cells as well as environmental variables, genetics, and lifestyle behaviors can play a role in the long-term inflammatory response. Researchers have commonly used immunohistochemistry, western blotting and gene sequencing to establish the cellular processes behind UC relapse and remission. However, because these destructive methods necessitate the removal of a sample, they can only be used on non-living tissues. The use of minimally invasive approaches to evaluate the

Indexed as

Dextran sulfate sodiumEndoscopyUlcerative colitis

Identifiers

PMID35692732
PMCPMC9178474
OpenAlexW4281896463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.